---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-072033"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-06-25T20:01:31+00:00"
generated_at: "2026-06-25T20:02:47.460305+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical CEO Brent Lucas receives updated compensation: $420k salary, $105k bonus target, 1M options, 1M RSUs

## Summary
- CEO Brent Lucas base salary raised to $420,000 per year, cash bonus targeted at $105,000 based on 2026-2027 strategic goals.
- Committee approved issuance of 1,000,000 stock options at $0.634 per share, vesting over four years.
- 1,000,000 restricted stock units granted, vesting upon FDA approval of Acclaim cochlear implant (performance period through June 18, 2030).
- RSU award is subject to Envoy Medical's 2023 Equity Incentive Plan and includes mandatory sale to cover withholding taxes.

## SEC filing metadata
- accession: 0001213900-26-072033
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-06-25T20:01:31+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026072033/0001213900-26-072033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026072033/ea0295990-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-072033
- JSON: https://secwatch.observer/filing/0001213900-26-072033.json
- Plain text: https://secwatch.observer/filing/0001213900-26-072033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.